Junwei Wang

9PUBLICATIONS
4CO-AUTHORS
Molecular targetsOrganometallic chemistryCheminformatics and quantitative structure-activity relationshipsF-block chemistryOrganic chemical synthesis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 27, 2025
Discovery of Novel Pyrrolo[2,3-b]pyridine-Based CSF-1R Inhibitors with Demonstrated Efficacy against Patient-Derived Colorectal Cancer Organoids.

Jinting He, Wen Gao, Rongrong Dong

|Apr 24, 2024
Discovery of a Novel Orally Bioavailable FLT3-PROTAC Degrader for Efficient Treatment of Acute Myeloid Leukemia and Overcoming Resistance of FLT3 Inhibitors.

Junwei Wang, Quanjin Rong, Lei Ye

|Apr 09, 2024
Discovery of a Novel CSF-1R Inhibitor with Highly Improved Pharmacokinetic Profiles and Superior Efficacy in Colorectal Cancer Immunotherapy.

Qi Lv, Hongqiong Yang, Dan Wang

|May 06, 2022
One-pot synthesis of indoles and quinolinones from ortho-tosylaminophenyl-substituted para-quinone methides.

Junwei Wang, Xiang Pan, Quanjin Rong

|Nov 04, 2021
Discovery of (Z)-1-(3-((1H-Pyrrol-2-yl)methylene)-2-oxoindolin-6-yl)-3-(isoxazol-3-yl)urea Derivatives as Novel and Orally Highly Effective CSF-1R Inhibitors for Potential Colorectal Cancer Immunotherapy.

Qi Lv, Xiang Pan, Dan Wang

|Apr 02, 2021
Discovery of a Potent and Selective FLT3 Inhibitor (Z)-N-(5-((5-Fluoro-2-oxoindolin-3-ylidene)methyl)-4-methyl-1H-pyrrol-3-yl)-3-(pyrrolidin-1-yl)propanamide with Improved Drug-like Properties and Superior Efficacy in FLT3-ITD-Positive Acute Myeloid Leukemia.

Junwei Wang, Xiang Pan, Yi Song

Pageof 2

Frequent Collaborators

2 joint publications

Kun Zhao

1 joint publications

Jian Liu

1 joint publications

Yinan Zhang

1 joint publications

Lihong Hu